Abiopharma

New Form 4/A - IONIS PHARMACEUTICALS INC Filed: 2026-01-20 AccNo: 0000874015-26-000068 Size: 5 KB

New Form SCHEDULE 13G - Nuwellis, Inc. Filed: 2026-01-20 AccNo: 0001535610-26-000012 Size: 9 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Synlogic, Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Synlogic, Inc. - Common Stock. New value: Synlogic, Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Synlogic, Inc. - Common Stock.

New Form SCHEDULE 13G - Lyra Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001535610-26-000011 Size: 9 KB

Agenus Inc. - Agenus to Host First 2026 Stakeholder Webcast

ResMed Inc. Daily Stock Update

OTCQB symbol attribute type Security_Name was changed. Previous value: -. New value: RENALYTIX PLC SP/ADR.

Tivic CEO To Present at the Upcoming Emerging Growths January 2026 Virtual Conference

New Form SCHEDULE 13D/A - EXICURE, INC. Filed: 2026-01-20 AccNo: 0002046701-26-000005 Size: 8 KB

enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.

Zhongchao Inc (ZCMD) Files Form 6-K

New Form 3 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2026-01-20 AccNo: 0001628280-26-002680 Size: 404 KB

New Form SCHEDULE 13G - ProQR Therapeutics N.V. Filed: 2026-01-20 AccNo: 0001104659-26-005130 Size: 24 KB